OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025 OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025 Featuring proprietary asset Tedopi® and two partnered SIRPα inhibitor assets with Boehringer Ingelheim NANTES, France – April 23, 2025, 6:00 p.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a biotech company dedicated to developing first-in-class therapies in immuno-oncology and immuno-inflammation, today announced that several abstracts highlighting the Company's innovative assets have been selected fo...
OSE Immunotherapeutics annonce la sélection de plusieurs abstracts pour présentation à l’ASCO 2025 OSE Immunotherapeutics annonce la sélection de plusieurs abstracts pour présentation à l’ASCO 2025Présentations sur l’actif propriétaire Tedopi® et sur deux inhibiteurs de SIRPα développés en partenariat avec Boehringer Ingelheim NANTES, France, 23 avril 2025, 18 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), une société de biotechnologie qui développe des traitements first-in-class en immuno-oncologie et en immuno-inflammation, annonce que plusieurs abstracts sur des ac...
Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 31 03 2025 DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTE AU 31 MARS 2025 Article L. 233-8-II du Code de CommerceArticle 223-16 du Règlement général de l’AMF Nombre d’actions composant le capital social236 664 445Nombre de droits de vote théoriques269 987 179Nombre de droits de vote exerçables267 518 854 Cette déclaration est en ligne sur le site internet d’Elis DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITALAND OF THE TOTAL NUMBER O...
Elis : Déclaration du nombre d'actions composant le capital et du nombre total de droits de vote au 31 03 2025 DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTE AU 31 MARS 2025 Article L. 233-8-II du Code de CommerceArticle 223-16 du Règlement général de l’AMF Nombre d’actions composant le capital social236 664 445Nombre de droits de vote théoriques269 987 179Nombre de droits de vote exerçables267 518 854 Cette déclaration est en ligne sur le site internet d’Elis DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITALAND OF THE TOTAL NUMBER OF VOTING...
Holding(s) in Company TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNR4T868 Issuer Name RENEWI PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of financial instruments 3. Details of person subject to the notification obligation Name Bank of America Corporation City of registered office (if applicable) Country of registered office (if applicable) US 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above City of registered office ...
Holding(s) in Company TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNR4T868 Issuer Name RENEWI PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name HSBC Holdings plc City of registered office (if applicable) London Country of registered office (if applicable) United Kingdom 4. Details of the shareholder Name City of registered office Country of registered office Internationale Kapitalanlagegesellschaft mit beschränkter HaftungDÜSSELDOR...
Holding(s) in Company TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNR4T868 Issuer Name RENEWI PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of financial instruments 3. Details of person subject to the notification obligation Name Bank of America Corporation City of registered office (if applicable) Country of registered office (if applicable) US 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above City of registered office ...
Elis: Disclosure of trading in own shares occured from April 15 to April 17, 2025 Disclosure of trading in own shares occurred from April 15 to April 17, 2025 Saint-Cloud, April 22, 2025 In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from April 15, 2025 to April 17, 2025 under the buyback program authorized by the 19th resolution of the General Shareholders' Meeting of May 23, 2024 and announced on March 6, 2025: Aggregated presentation: Issuer name Issuer code(LEI) Tran...
Elis : Déclaration des transactions sur actions propres du 15 au 17 avril 2025 Déclaration des transactions sur actions propres réalisées du 15 au 17 avril 2025 Saint-Cloud, le 22 avril 2025 Conformément à la réglementation relative aux rachats d’actions, notamment le Règlement (UE) 2016/1052, Elis déclare ci-après les achats d’actions propres réalisés du 15 avril 2025 au 17 avril 2025 dans le cadre du programme de rachat autorisé par la 19ème résolution du l’assemblée générale des actionnaires du 23 mai 2024 et annoncé le 6 mars 2025 : Présentation agrégée : Nom del'émetteurCode Identi...
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Renewi plc 21-Apr-2025 / 16:42 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settl...
Holding(s) in Company TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNR4T868 Issuer Name RENEWI PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of financial instruments 3. Details of person subject to the notification obligation Name Bank of America Corporation City of registered office (if applicable) Country of registered office (if applicable) US 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above City of registered office ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.